My Companies
Notification
Account
Q1 FY27 Standalone Results YoY: NII at 19.2 Cr vs 21.4 Cr, down 10.3%. PPOP at 6.5 Cr vs 8.4 Cr, down 22.4%. PAT at 4.2 Cr vs 4.1 Cr, up 1.6%; supported by impairment reversal of 1.2 Cr versus provision of 1.0 Cr in the prior year. GNPA improved to 4.6% from 4.7%, while NNPA increased to 2.2% from 2.2%; PCR declined to 53.2% from 54.9%. CRAR strengthened to 19.9% from 18.4%. The company timely redeemed NCDs of 25.5 Cr plus 5.2 Cr interest, with security cover maintained at 1.10x. Board approved unlisted redeemable cumulative preference shares of up to 50 Cr, carrying a coupon of up to 12%, subject to shareholder approval.
No events have occurred recently